

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | androgen metabolic process (GO:0008209) | 9.93676557 |
| 2 | positive regulation of growth hormone secretion (GO:0060124) | 9.58480049 |
| 3 | multi-organism reproductive process (GO:0044703) | 9.52911910 |
| 4 | glucocorticoid metabolic process (GO:0008211) | 8.06893012 |
| 5 | hormone biosynthetic process (GO:0042446) | 7.44736466 |
| 6 | regulation of growth hormone secretion (GO:0060123) | 6.85576155 |
| 7 | vitamin transmembrane transport (GO:0035461) | 6.60483698 |
| 8 | collecting duct development (GO:0072044) | 6.30375723 |
| 9 | response to gonadotropin (GO:0034698) | 6.08783614 |
| 10 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 6.08306226 |
| 11 | myoblast fusion (GO:0007520) | 6.05750458 |
| 12 | syncytium formation (GO:0006949) | 5.94677705 |
| 13 | endocrine hormone secretion (GO:0060986) | 5.68812810 |
| 14 | negative regulation of activin receptor signaling pathway (GO:0032926) | 5.47737252 |
| 15 | protein neddylation (GO:0045116) | 5.39221963 |
| 16 | syncytium formation by plasma membrane fusion (GO:0000768) | 5.31000082 |
| 17 | positive regulation of protein kinase C signaling (GO:0090037) | 5.13489435 |
| 18 | lymphangiogenesis (GO:0001946) | 4.93220187 |
| 19 | sphingoid metabolic process (GO:0046519) | 4.79073215 |
| 20 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.61566526 |
| 21 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 4.53881658 |
| 22 | lymph vessel development (GO:0001945) | 4.48583954 |
| 23 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.41463349 |
| 24 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.40404654 |
| 25 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 4.38652579 |
| 26 | bone morphogenesis (GO:0060349) | 4.28946466 |
| 27 | estrogen biosynthetic process (GO:0006703) | 33.5299926 |
| 28 | T-helper 1 type immune response (GO:0042088) | 3.75126155 |
| 29 | myelin maintenance (GO:0043217) | 3.72620796 |
| 30 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 3.65096399 |
| 31 | regulation of G0 to G1 transition (GO:0070316) | 3.51783768 |
| 32 | regulation of endocrine process (GO:0044060) | 3.51209152 |
| 33 | cellular hormone metabolic process (GO:0034754) | 3.40611388 |
| 34 | sprouting angiogenesis (GO:0002040) | 3.39465820 |
| 35 | parturition (GO:0007567) | 3.38851492 |
| 36 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.11604726 |
| 37 | eyelid development in camera-type eye (GO:0061029) | 3.08095330 |
| 38 | steroid biosynthetic process (GO:0006694) | 3.01261565 |
| 39 | interkinetic nuclear migration (GO:0022027) | 2.99181495 |
| 40 | keratinocyte development (GO:0003334) | 2.97988333 |
| 41 | polarized epithelial cell differentiation (GO:0030859) | 2.92808913 |
| 42 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.90168815 |
| 43 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.85733846 |
| 44 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.83164474 |
| 45 | transcytosis (GO:0045056) | 2.81958050 |
| 46 | progesterone metabolic process (GO:0042448) | 2.78055758 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.76205150 |
| 48 | mitotic cytokinesis (GO:0000281) | 2.70997859 |
| 49 | iron ion import (GO:0097286) | 2.68188368 |
| 50 | ketone biosynthetic process (GO:0042181) | 2.60784821 |
| 51 | ear development (GO:0043583) | 2.58260734 |
| 52 | Sertoli cell development (GO:0060009) | 2.51314093 |
| 53 | basement membrane organization (GO:0071711) | 2.44816404 |
| 54 | negative regulation of cell-matrix adhesion (GO:0001953) | 2.43369161 |
| 55 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.38501081 |
| 56 | positive regulation of digestive system process (GO:0060456) | 2.38290204 |
| 57 | response to phenylpropanoid (GO:0080184) | 2.35899778 |
| 58 | sphingosine metabolic process (GO:0006670) | 2.33309556 |
| 59 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.33004697 |
| 60 | Leydig cell differentiation (GO:0033327) | 2.32591758 |
| 61 | hormone metabolic process (GO:0042445) | 2.32392752 |
| 62 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.32040605 |
| 63 | regulation of activin receptor signaling pathway (GO:0032925) | 2.28498070 |
| 64 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.25134670 |
| 65 | regulation of protein kinase C signaling (GO:0090036) | 2.21931112 |
| 66 | thyroid hormone generation (GO:0006590) | 2.19441381 |
| 67 | histone H2A monoubiquitination (GO:0035518) | 2.19132664 |
| 68 | bone trabecula formation (GO:0060346) | 2.12802207 |
| 69 | negative regulation of macrophage differentiation (GO:0045650) | 2.12126708 |
| 70 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.11555044 |
| 71 | vitamin D metabolic process (GO:0042359) | 2.05002341 |
| 72 | negative regulation of organ growth (GO:0046621) | 2.04660710 |
| 73 | regulation of ruffle assembly (GO:1900027) | 2.03910285 |
| 74 | diol metabolic process (GO:0034311) | 2.02375438 |
| 75 | response to follicle-stimulating hormone (GO:0032354) | 15.8341180 |
| 76 | female pregnancy (GO:0007565) | 15.1639873 |
| 77 | regulation of gonadotropin secretion (GO:0032276) | 14.4047046 |
| 78 | estrogen metabolic process (GO:0008210) | 14.3408156 |
| 79 | glucocorticoid biosynthetic process (GO:0006704) | 13.9354150 |
| 80 | prostate gland growth (GO:0060736) | 13.6124931 |
| 81 | androgen biosynthetic process (GO:0006702) | 11.4601300 |
| 82 | multi-multicellular organism process (GO:0044706) | 10.9748765 |
| 83 | response to insecticide (GO:0017085) | 1.99623389 |
| 84 | placenta development (GO:0001890) | 1.93719465 |
| 85 | regulation of NIK/NF-kappaB signaling (GO:1901222) | 1.93598073 |
| 86 | apical protein localization (GO:0045176) | 1.93433137 |
| 87 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 1.92584978 |
| 88 | female genitalia development (GO:0030540) | 1.91267976 |
| 89 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 1.88370028 |
| 90 | C21-steroid hormone metabolic process (GO:0008207) | 1.88109888 |
| 91 | thyroid hormone metabolic process (GO:0042403) | 1.86805665 |
| 92 | blood vessel morphogenesis (GO:0048514) | 1.86374346 |
| 93 | response to inactivity (GO:0014854) | 1.84312443 |
| 94 | positive regulation of steroid hormone secretion (GO:2000833) | 1.83661490 |
| 95 | regulation of clathrin-mediated endocytosis (GO:2000369) | 1.83066335 |
| 96 | mitotic G2 DNA damage checkpoint (GO:0007095) | 1.81349467 |
| 97 | positive regulation of T cell cytokine production (GO:0002726) | 1.80273227 |
| 98 | regulation of alpha-beta T cell proliferation (GO:0046640) | 1.78388493 |
| 99 | vitamin transport (GO:0051180) | 1.78268311 |
| 100 | cellular response to exogenous dsRNA (GO:0071360) | 1.77310633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19032775_ChIP-ChIP_M12_Human | 6.67629392 |
| 2 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.61305762 |
| 3 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 3.56476419 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.09196070 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.88091392 |
| 6 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 2.84943080 |
| 7 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.62016570 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.40791728 |
| 9 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.36823098 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.36082104 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.21424160 |
| 12 | TP53_18474530_ChIP-ChIP_U2OS_Human | 2.16469342 |
| 13 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.06033840 |
| 14 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.05416349 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 14.7733284 |
| 16 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.87715523 |
| 17 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.82828375 |
| 18 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.74772538 |
| 19 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.74738607 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71976743 |
| 21 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.68230972 |
| 22 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.67200846 |
| 23 | EWS_26573619_Chip-Seq_HEK293_Human | 1.64764019 |
| 24 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.57652628 |
| 25 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.41886729 |
| 26 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.41886729 |
| 27 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41116950 |
| 28 | FUS_26573619_Chip-Seq_HEK293_Human | 1.40919835 |
| 29 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37470439 |
| 30 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36032422 |
| 31 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.35049940 |
| 32 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26566696 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.26051189 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24025970 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.20232803 |
| 36 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.19445799 |
| 37 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.19069579 |
| 38 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.18952419 |
| 39 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.18446030 |
| 40 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.18446030 |
| 41 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.18442757 |
| 42 | RXR_22108803_ChIP-Seq_LS180_Human | 1.16204288 |
| 43 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.15625809 |
| 44 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15041036 |
| 45 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12731881 |
| 46 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.12503999 |
| 47 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.11177228 |
| 48 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10411188 |
| 49 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.10273172 |
| 50 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09803788 |
| 51 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09331702 |
| 52 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08440075 |
| 53 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.07953936 |
| 54 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.07953936 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06355242 |
| 56 | JUN_21703547_ChIP-Seq_K562_Human | 1.04578571 |
| 57 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03954926 |
| 58 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03954926 |
| 59 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03635346 |
| 60 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03635346 |
| 61 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01463423 |
| 62 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.99418816 |
| 63 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.96790829 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96128003 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95345105 |
| 66 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93961707 |
| 67 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.93825835 |
| 68 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.92308926 |
| 69 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.90589597 |
| 70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88589906 |
| 71 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.88336943 |
| 72 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.87129493 |
| 73 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87059915 |
| 74 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.85447634 |
| 75 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85423146 |
| 76 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.83606392 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82709629 |
| 78 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.81605494 |
| 79 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.80995188 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.80942859 |
| 81 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.79954172 |
| 82 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.79054691 |
| 83 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77318004 |
| 84 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77049692 |
| 85 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.76957625 |
| 86 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.75758484 |
| 87 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.75094630 |
| 88 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.74515774 |
| 89 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.73807073 |
| 90 | TBL1_22424771_ChIP-Seq_293T_Human | 0.73559056 |
| 91 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.73077652 |
| 92 | P300_27268052_Chip-Seq_Bcells_Human | 0.70927276 |
| 93 | NFYA_21822215_ChIP-Seq_K562_Human | 0.70764757 |
| 94 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.69835454 |
| 95 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.68045937 |
| 96 | CJUN_26792858_Chip-Seq_BT549_Human | 0.67960223 |
| 97 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.67510166 |
| 98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.66439620 |
| 99 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.65142112 |
| 100 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.64227663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002163_abnormal_gland_morphology | 6.93508659 |
| 2 | MP0005379_endocrine/exocrine_gland_phen | 5.30524829 |
| 3 | MP0006276_abnormal_autonomic_nervous | 5.08282294 |
| 4 | MP0005647_abnormal_sex_gland | 3.79156092 |
| 5 | MP0001919_abnormal_reproductive_system | 3.73966994 |
| 6 | MP0010368_abnormal_lymphatic_system | 3.61667238 |
| 7 | MP0003941_abnormal_skin_development | 3.10465810 |
| 8 | MP0000013_abnormal_adipose_tissue | 2.98978809 |
| 9 | MP0001440_abnormal_grooming_behavior | 2.57087008 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 2.32031894 |
| 11 | MP0000003_abnormal_adipose_tissue | 2.31304021 |
| 12 | MP0003959_abnormal_lean_body | 2.28181964 |
| 13 | MP0005389_reproductive_system_phenotype | 2.23617892 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.13699425 |
| 15 | MP0009697_abnormal_copulation | 11.9800970 |
| 16 | MP0006054_spinal_hemorrhage | 1.91809684 |
| 17 | MP0002653_abnormal_ependyma_morphology | 1.82433509 |
| 18 | MP0001666_abnormal_nutrient_absorption | 1.81860172 |
| 19 | MP0009115_abnormal_fat_cell | 1.79781404 |
| 20 | MP0003936_abnormal_reproductive_system | 1.65694118 |
| 21 | MP0000613_abnormal_salivary_gland | 1.61365306 |
| 22 | MP0009703_decreased_birth_body | 1.55356001 |
| 23 | MP0006138_congestive_heart_failure | 1.46614193 |
| 24 | MP0001879_abnormal_lymphatic_vessel | 1.43505902 |
| 25 | MP0000647_abnormal_sebaceous_gland | 1.40815447 |
| 26 | MP0010329_abnormal_lipoprotein_level | 1.34407129 |
| 27 | MP0002971_abnormal_brown_adipose | 1.31073048 |
| 28 | MP0005375_adipose_tissue_phenotype | 1.27164532 |
| 29 | MP0000639_abnormal_adrenal_gland | 1.26115847 |
| 30 | MP0001756_abnormal_urination | 1.21587735 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.19000311 |
| 32 | MP0002998_abnormal_bone_remodeling | 1.18820643 |
| 33 | MP0002075_abnormal_coat/hair_pigmentati | 1.18197801 |
| 34 | MP0003453_abnormal_keratinocyte_physiol | 1.00427514 |
| 35 | MP0005023_abnormal_wound_healing | 0.99677146 |
| 36 | MP0004185_abnormal_adipocyte_glucose | 0.92317444 |
| 37 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91774960 |
| 38 | MP0003136_yellow_coat_color | 0.90464988 |
| 39 | MP0004085_abnormal_heartbeat | 0.86601238 |
| 40 | MP0000230_abnormal_systemic_arterial | 0.84773539 |
| 41 | MP0001186_pigmentation_phenotype | 0.81147906 |
| 42 | MP0002086_abnormal_extraembryonic_tissu | 0.80641050 |
| 43 | MP0005334_abnormal_fat_pad | 0.79678724 |
| 44 | MP0009379_abnormal_foot_pigmentation | 0.79561187 |
| 45 | MP0002909_abnormal_adrenal_gland | 0.77486328 |
| 46 | MP0008057_abnormal_DNA_replication | 0.76024004 |
| 47 | MP0001915_intracranial_hemorrhage | 0.75676587 |
| 48 | MP0002557_abnormal_social/conspecific_i | 0.73370207 |
| 49 | MP0001765_abnormal_ion_homeostasis | 0.71273360 |
| 50 | MP0002210_abnormal_sex_determination | 0.70082149 |
| 51 | MP0005319_abnormal_enzyme/_coenzyme | 0.69495309 |
| 52 | MP0002128_abnormal_blood_circulation | 0.68132820 |
| 53 | MP0001119_abnormal_female_reproductive | 0.67165709 |
| 54 | MP0004947_skin_inflammation | 0.66160908 |
| 55 | MP0002972_abnormal_cardiac_muscle | 0.66000990 |
| 56 | MP0002254_reproductive_system_inflammat | 0.60951348 |
| 57 | MP0003122_maternal_imprinting | 0.59469690 |
| 58 | MP0003385_abnormal_body_wall | 0.58473050 |
| 59 | MP0001340_abnormal_eyelid_morphology | 0.57214369 |
| 60 | MP0005636_abnormal_mineral_homeostasis | 0.56966234 |
| 61 | MP0003699_abnormal_female_reproductive | 0.56479429 |
| 62 | MP0003566_abnormal_cell_adhesion | 0.53384721 |
| 63 | MP0005452_abnormal_adipose_tissue | 0.52571928 |
| 64 | MP0003795_abnormal_bone_structure | 0.51409948 |
| 65 | MP0004782_abnormal_surfactant_physiolog | 0.49327715 |
| 66 | MP0004145_abnormal_muscle_electrophysio | 0.46974195 |
| 67 | MP0001929_abnormal_gametogenesis | 0.46745861 |
| 68 | MP0000681_abnormal_thyroid_gland | 0.46178649 |
| 69 | MP0001188_hyperpigmentation | 0.46020857 |
| 70 | MP0004272_abnormal_basement_membrane | 0.45081350 |
| 71 | MP0000367_abnormal_coat/_hair | 0.44099262 |
| 72 | MP0005385_cardiovascular_system_phenoty | 0.43941516 |
| 73 | MP0001544_abnormal_cardiovascular_syste | 0.43941516 |
| 74 | MP0000685_abnormal_immune_system | 0.42741518 |
| 75 | MP0000598_abnormal_liver_morphology | 0.42576209 |
| 76 | MP0003724_increased_susceptibility_to | 0.42228301 |
| 77 | MP0004147_increased_porphyrin_level | 0.41772521 |
| 78 | MP0000653_abnormal_sex_gland | 0.41726019 |
| 79 | MP0000266_abnormal_heart_morphology | 0.40657775 |
| 80 | MP0002295_abnormal_pulmonary_circulatio | 0.39417405 |
| 81 | MP0001730_embryonic_growth_arrest | 0.39131063 |
| 82 | MP0000627_abnormal_mammary_gland | 0.38904259 |
| 83 | MP0002084_abnormal_developmental_patter | 0.37949505 |
| 84 | MP0009672_abnormal_birth_weight | 0.35034475 |
| 85 | MP0003953_abnormal_hormone_level | 0.34689805 |
| 86 | MP0006035_abnormal_mitochondrial_morpho | 0.34115310 |
| 87 | MP0001145_abnormal_male_reproductive | 0.33995744 |
| 88 | MP0003698_abnormal_male_reproductive | 0.32282737 |
| 89 | MP0001545_abnormal_hematopoietic_system | 0.31736485 |
| 90 | MP0005397_hematopoietic_system_phenotyp | 0.31736485 |
| 91 | MP0003718_maternal_effect | 0.31456741 |
| 92 | MP0002160_abnormal_reproductive_system | 0.29464172 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.28915133 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.28485224 |
| 95 | MP0001881_abnormal_mammary_gland | 0.27636445 |
| 96 | MP0000427_abnormal_hair_cycle | 0.27328798 |
| 97 | MP0008875_abnormal_xenobiotic_pharmacok | 0.26920916 |
| 98 | MP0002925_abnormal_cardiovascular_devel | 0.26806658 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.25430392 |
| 100 | MP0000759_abnormal_skeletal_muscle | 0.25356444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypergonadotropic hypogonadism (HP:0000815) | 9.05900605 |
| 2 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 8.40338448 |
| 3 | Upper limb muscle weakness (HP:0003484) | 8.34654656 |
| 4 | Abnormal pupillary function (HP:0007686) | 6.97957533 |
| 5 | Abnormal auditory evoked potentials (HP:0006958) | 6.41710975 |
| 6 | Muscle fibrillation (HP:0010546) | 6.23484106 |
| 7 | Nonimmune hydrops fetalis (HP:0001790) | 6.02186202 |
| 8 | Tongue fasciculations (HP:0001308) | 5.97855792 |
| 9 | Female pseudohermaphroditism (HP:0010458) | 5.84635417 |
| 10 | Accelerated skeletal maturation (HP:0005616) | 5.83255256 |
| 11 | Anosmia (HP:0000458) | 5.49619214 |
| 12 | Bilateral microphthalmos (HP:0007633) | 4.79710100 |
| 13 | Basal cell carcinoma (HP:0002671) | 4.41071133 |
| 14 | Gynecomastia (HP:0000771) | 4.32367424 |
| 15 | Back pain (HP:0003418) | 4.28354305 |
| 16 | Hypogonadotrophic hypogonadism (HP:0000044) | 4.25135663 |
| 17 | Lower limb asymmetry (HP:0100559) | 4.03410218 |
| 18 | Primary amenorrhea (HP:0000786) | 3.76802181 |
| 19 | Abnormality of the ischium (HP:0003174) | 3.34027926 |
| 20 | Areflexia of lower limbs (HP:0002522) | 3.20135469 |
| 21 | Sex reversal (HP:0012245) | 3.06403490 |
| 22 | Abnormal sex determination (HP:0012244) | 3.06403490 |
| 23 | Bicornuate uterus (HP:0000813) | 3.06398466 |
| 24 | Abnormal pancreas size (HP:0012094) | 3.01765067 |
| 25 | Pseudobulbar signs (HP:0002200) | 2.97419208 |
| 26 | Arteriovenous malformation (HP:0100026) | 2.95493002 |
| 27 | Long palpebral fissure (HP:0000637) | 2.88779696 |
| 28 | Delayed gross motor development (HP:0002194) | 2.80906720 |
| 29 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.65780597 |
| 30 | Onion bulb formation (HP:0003383) | 2.65667764 |
| 31 | Long eyelashes (HP:0000527) | 2.64032494 |
| 32 | Confusion (HP:0001289) | 2.63314414 |
| 33 | Disproportionate tall stature (HP:0001519) | 2.60540222 |
| 34 | Genu valgum (HP:0002857) | 2.58430105 |
| 35 | Peripheral demyelination (HP:0011096) | 2.53240736 |
| 36 | Ectopic kidney (HP:0000086) | 2.50122502 |
| 37 | Hyperaldosteronism (HP:0000859) | 2.45259643 |
| 38 | Venous insufficiency (HP:0005293) | 2.43676706 |
| 39 | Anophthalmia (HP:0000528) | 2.43289156 |
| 40 | Abnormality of the aortic arch (HP:0012303) | 2.37015517 |
| 41 | Abnormal lung lobation (HP:0002101) | 2.32738428 |
| 42 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.29684666 |
| 43 | Testicular neoplasm (HP:0010788) | 2.29288467 |
| 44 | Hematochezia (HP:0002573) | 2.26566822 |
| 45 | Wormian bones (HP:0002645) | 2.24242043 |
| 46 | Abnormality of the pupil (HP:0000615) | 2.20862284 |
| 47 | Aplasia of the musculature (HP:0100854) | 2.19419544 |
| 48 | Asymmetric growth (HP:0100555) | 2.18412034 |
| 49 | Myotonia (HP:0002486) | 2.15645601 |
| 50 | Morphological abnormality of the middle ear (HP:0008609) | 2.14535018 |
| 51 | Renal salt wasting (HP:0000127) | 2.11538138 |
| 52 | Difficulty walking (HP:0002355) | 2.09077710 |
| 53 | Abnormality of the nasolacrimal system (HP:0000614) | 2.08090073 |
| 54 | Coarctation of aorta (HP:0001680) | 2.07421871 |
| 55 | Hypoplasia of the uterus (HP:0000013) | 2.04170470 |
| 56 | Decreased motor nerve conduction velocity (HP:0003431) | 2.03845174 |
| 57 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.03116195 |
| 58 | Decreased circulating renin level (HP:0003351) | 2.02932947 |
| 59 | Impulsivity (HP:0100710) | 2.02287077 |
| 60 | Capillary hemangiomas (HP:0005306) | 10.2856995 |
| 61 | Flat cornea (HP:0007720) | 1.99587950 |
| 62 | Short tibia (HP:0005736) | 1.96534671 |
| 63 | Hypoplastic nipples (HP:0002557) | 1.91747099 |
| 64 | Venous abnormality (HP:0002624) | 1.89579972 |
| 65 | Mutism (HP:0002300) | 1.88418299 |
| 66 | Spontaneous hematomas (HP:0007420) | 1.87990189 |
| 67 | Small intestinal stenosis (HP:0012848) | 1.86805411 |
| 68 | Duodenal stenosis (HP:0100867) | 1.86805411 |
| 69 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.86774375 |
| 70 | Colon cancer (HP:0003003) | 1.84700054 |
| 71 | Abnormality of secondary sexual hair (HP:0009888) | 1.81824274 |
| 72 | Abnormality of the axillary hair (HP:0100134) | 1.81824274 |
| 73 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.80865459 |
| 74 | Breast hypoplasia (HP:0003187) | 1.80798082 |
| 75 | Fasciculations (HP:0002380) | 1.79735170 |
| 76 | Abnormality of the lacrimal duct (HP:0011481) | 1.75437405 |
| 77 | Depressed nasal tip (HP:0000437) | 1.74953031 |
| 78 | Hypohidrosis (HP:0000966) | 1.73466747 |
| 79 | Polycythemia (HP:0001901) | 1.72458064 |
| 80 | Annular pancreas (HP:0001734) | 1.72266123 |
| 81 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.69102199 |
| 82 | Long clavicles (HP:0000890) | 1.68460305 |
| 83 | Clubbing of toes (HP:0100760) | 1.66787852 |
| 84 | Absent eyebrow (HP:0002223) | 1.66748756 |
| 85 | Right ventricular cardiomyopathy (HP:0011663) | 1.64692289 |
| 86 | Severe Myopia (HP:0011003) | 1.64589409 |
| 87 | Fragile skin (HP:0001030) | 1.64307837 |
| 88 | Inability to walk (HP:0002540) | 1.63236157 |
| 89 | Bifid tongue (HP:0010297) | 1.62286591 |
| 90 | Abnormality of pain sensation (HP:0010832) | 1.61976035 |
| 91 | Impaired pain sensation (HP:0007328) | 1.61976035 |
| 92 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.60531798 |
| 93 | Aplasia cutis congenita (HP:0001057) | 1.60396336 |
| 94 | Cardiovascular calcification (HP:0011915) | 1.59052746 |
| 95 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.58814074 |
| 96 | Lymphedema (HP:0001004) | 1.54998794 |
| 97 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.54326687 |
| 98 | Nasal speech (HP:0001611) | 1.52401189 |
| 99 | Hyperpituitarism (HP:0010514) | 1.51314372 |
| 100 | Sparse lateral eyebrow (HP:0005338) | 1.51123408 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDGFRA | 6.06137895 |
| 2 | AKT3 | 5.38221680 |
| 3 | DAPK2 | 4.53802602 |
| 4 | MST4 | 3.27450302 |
| 5 | BLK | 2.54978631 |
| 6 | PDGFRB | 2.19887863 |
| 7 | TIE1 | 2.09939320 |
| 8 | KDR | 10.6539707 |
| 9 | ICK | 1.85529305 |
| 10 | DAPK1 | 1.78842158 |
| 11 | PKN1 | 1.42627027 |
| 12 | NME1 | 1.39286522 |
| 13 | TAF1 | 1.36768696 |
| 14 | ERBB4 | 1.20717534 |
| 15 | FRK | 1.18140252 |
| 16 | DAPK3 | 1.14900858 |
| 17 | INSRR | 0.99811591 |
| 18 | INSR | 0.96904757 |
| 19 | SRC | 0.94701586 |
| 20 | EGFR | 0.92144650 |
| 21 | STK16 | 0.90195514 |
| 22 | VRK2 | 0.82051902 |
| 23 | LATS1 | 0.80794489 |
| 24 | NEK9 | 0.73362599 |
| 25 | PBK | 0.71919547 |
| 26 | PDPK1 | 0.70637371 |
| 27 | BUB1 | 0.70080161 |
| 28 | FES | 0.67773184 |
| 29 | WNK3 | 0.67651089 |
| 30 | CSNK1A1L | 0.66702543 |
| 31 | AURKB | 0.66518791 |
| 32 | RPS6KA2 | 0.64963909 |
| 33 | SMG1 | 0.64451536 |
| 34 | RPS6KA6 | 0.64292526 |
| 35 | MAP3K7 | 0.62247261 |
| 36 | SRPK1 | 0.62072809 |
| 37 | RPS6KL1 | 0.61235556 |
| 38 | RPS6KC1 | 0.61235556 |
| 39 | MKNK2 | 0.57071771 |
| 40 | NME2 | 0.56318564 |
| 41 | AKT2 | 0.54139137 |
| 42 | TAOK3 | 0.52544390 |
| 43 | STK10 | 0.50824151 |
| 44 | PTK6 | 0.50563567 |
| 45 | ZAK | 0.46655534 |
| 46 | NUAK1 | 0.43774105 |
| 47 | TGFBR2 | 0.43034853 |
| 48 | PRKCZ | 0.42926101 |
| 49 | BMPR1B | 0.42459964 |
| 50 | CSNK1G1 | 0.38776228 |
| 51 | MET | 0.38155742 |
| 52 | LYN | 0.37541092 |
| 53 | MAPK13 | 0.37272918 |
| 54 | MAP3K12 | 0.36100452 |
| 55 | MKNK1 | 0.35516668 |
| 56 | BRSK2 | 0.35334992 |
| 57 | DYRK2 | 0.34950050 |
| 58 | TYK2 | 0.34663496 |
| 59 | CDC7 | 0.33228177 |
| 60 | TRPM7 | 0.32823348 |
| 61 | TTK | 0.32668360 |
| 62 | SGK494 | 0.32038589 |
| 63 | SGK223 | 0.32038589 |
| 64 | PRKCA | 0.31124550 |
| 65 | STK38 | 0.30454347 |
| 66 | SGK1 | 0.30375873 |
| 67 | PRKCQ | 0.30011046 |
| 68 | YES1 | 0.29346934 |
| 69 | JAK2 | 0.29095733 |
| 70 | CSNK1G3 | 0.26048802 |
| 71 | MYLK | 0.25594583 |
| 72 | PRKCE | 0.25348214 |
| 73 | NLK | 0.24142580 |
| 74 | MAPK4 | 0.24068932 |
| 75 | LCK | 0.22790225 |
| 76 | RPS6KB2 | 0.22733812 |
| 77 | PLK1 | 0.22601159 |
| 78 | PIK3CA | 0.22512691 |
| 79 | PRKD2 | 0.22495179 |
| 80 | KIT | 0.22419088 |
| 81 | PDK1 | 0.22326199 |
| 82 | EPHA2 | 0.22218432 |
| 83 | TXK | 0.22125413 |
| 84 | CDK19 | 0.22007830 |
| 85 | STK3 | 0.21050366 |
| 86 | PLK4 | 0.20882278 |
| 87 | PRKD1 | 0.20843918 |
| 88 | TESK2 | 0.17483957 |
| 89 | MARK2 | 0.16778074 |
| 90 | MAP2K1 | 0.16664932 |
| 91 | HCK | 0.16663471 |
| 92 | RPS6KA1 | 0.16130229 |
| 93 | CSNK1G2 | 0.15785578 |
| 94 | RIPK1 | 0.15685320 |
| 95 | MTOR | 0.15374072 |
| 96 | MELK | 0.14989285 |
| 97 | STK24 | 0.13876879 |
| 98 | VRK1 | 0.13501112 |
| 99 | DYRK1B | 0.13458072 |
| 100 | FER | 0.12697647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 8.73666126 |
| 2 | Folate biosynthesis_Homo sapiens_hsa00790 | 3.20983308 |
| 3 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 3.01349798 |
| 4 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.40467753 |
| 5 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 2.13280745 |
| 6 | Mineral absorption_Homo sapiens_hsa04978 | 2.00938638 |
| 7 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 10.2679070 |
| 8 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.96067970 |
| 9 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.86897145 |
| 10 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.85872443 |
| 11 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.68625203 |
| 12 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.54595618 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25887692 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13936881 |
| 15 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.11111574 |
| 16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.04476074 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.02240076 |
| 18 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.99742816 |
| 19 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.96276231 |
| 20 | Axon guidance_Homo sapiens_hsa04360 | 0.93458764 |
| 21 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88259812 |
| 22 | RNA polymerase_Homo sapiens_hsa03020 | 0.70905959 |
| 23 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68128050 |
| 24 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66741454 |
| 25 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66483795 |
| 26 | Tight junction_Homo sapiens_hsa04530 | 0.66154315 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65677210 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.65499141 |
| 29 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.63051482 |
| 30 | Mismatch repair_Homo sapiens_hsa03430 | 0.62646612 |
| 31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.62207620 |
| 32 | Focal adhesion_Homo sapiens_hsa04510 | 0.61690857 |
| 33 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61644396 |
| 34 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58772021 |
| 35 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56818716 |
| 36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52086953 |
| 37 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52068645 |
| 38 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51874459 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.51852817 |
| 40 | Spliceosome_Homo sapiens_hsa03040 | 0.50993696 |
| 41 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49498934 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49062543 |
| 43 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.44819994 |
| 44 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42159581 |
| 45 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41657692 |
| 46 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.38198228 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.37748168 |
| 48 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.37084949 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.36602624 |
| 50 | Homologous recombination_Homo sapiens_hsa03440 | 0.35882490 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35118253 |
| 52 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34978124 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.33731464 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 0.33544470 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 0.31805183 |
| 56 | RNA transport_Homo sapiens_hsa03013 | 0.30621478 |
| 57 | Pathways in cancer_Homo sapiens_hsa05200 | 0.28559544 |
| 58 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.28532302 |
| 59 | Proteasome_Homo sapiens_hsa03050 | 0.26449064 |
| 60 | Prostate cancer_Homo sapiens_hsa05215 | 0.25394438 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.24697006 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.23881634 |
| 63 | Nicotine addiction_Homo sapiens_hsa05033 | 0.23116872 |
| 64 | Adherens junction_Homo sapiens_hsa04520 | 0.22140107 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.21789892 |
| 66 | Huntingtons disease_Homo sapiens_hsa05016 | 0.21612774 |
| 67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.20809458 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20182919 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19007152 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.18067843 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.17039402 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.15111220 |
| 73 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.14935317 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.13810547 |
| 75 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.11520691 |
| 76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.11413197 |
| 77 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.11187249 |
| 78 | Olfactory transduction_Homo sapiens_hsa04740 | 0.11046655 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.10447172 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.10402481 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.09741914 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.08908176 |
| 83 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.08402807 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.06368829 |
| 85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.06129840 |
| 86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.05222065 |
| 87 | Long-term depression_Homo sapiens_hsa04730 | 0.03978448 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.03756691 |
| 89 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.03512694 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.03077284 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.02501533 |
| 92 | Cell cycle_Homo sapiens_hsa04110 | 0.02232788 |
| 93 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.01972928 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.01718302 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.01258035 |
| 96 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.00961035 |
| 97 | Ribosome_Homo sapiens_hsa03010 | 0.00647307 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | -0.0096004 |
| 99 | DNA replication_Homo sapiens_hsa03030 | -0.0067986 |
| 100 | Hepatitis B_Homo sapiens_hsa05161 | -0.0067614 |

